Ribavirin
- Product NDC
- 0781-2043
- 11-digit product format
- 007812043
- Labeler code
- 0781
- Product ID
- 0781-2043_52ecf3bd-6c80-4361-804c-dac97bd735cb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ribavirin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sandoz Inc
- Application
- ANDA076192
- Marketing category
- ANDA
- Marketing start
- 2004-04-06
- Marketing end
- 0000-00-00
- Substance
- RIBAVIRIN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 69d6a460-3e15-2628-a0df-cebee0ce913f | Product name | 2 | 20161206 |
| 96c088f7-fe95-75d0-c542-fbc93a6056a0 | Product name | 2 | 20150305 |
| c551530a-adb3-42db-bf59-f11bd7d25fbf | Product name | 1 | 20150305 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-2043-04 | EA - Each | 0781-2043 | d2982526-6663-4e09-a15a-05bb0843c13b | 1 | 2012-07-24 |
| 0781-2043-16 | EA - Each | 0781-2043 | 706bd3e5-1302-4eed-ab72-ac20c6c43681 | 1 | 2012-07-24 |
| 0781-2043-42 | EA - Each | 0781-2043 | ec20a47f-70b6-4d7f-be16-136b95eb2ec2 | 1 | 2012-07-24 |
| 0781-2043-67 | EA - Each | 0781-2043 | 0aff3ed1-2934-467d-90b0-18bf57795165 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312817 | ribavirin 200 MG Oral Capsule | PSN | 3b8b0c65-e466-4662-9e85-5a253d31ebe8 | 1 |
| 312817 | ribavirin 200 MG Oral Capsule | SCD | 3b8b0c65-e466-4662-9e85-5a253d31ebe8 | 1 |